메뉴 건너뛰기




Volumn 50, Issue 2, 2010, Pages 188-194

Effect of grapefruit juice on the pharmacokinetics of nilotinib in healthy participants

Author keywords

Grapefruit juice; Nilotinib; Pharmacokinetics

Indexed keywords

NILOTINIB;

EID: 75749106656     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1177/0091270009336137     Document Type: Article
Times cited : (68)

References (23)
  • 1
    • 0026099498 scopus 로고
    • Interaction of citrus juices with felodipine and nifedipine
    • Bailey DG, Spence JD, Munoz, C., Arnold JM Interaction of citrus juices with felodipine and nifedipine. Lancet. 1991 ; 337: 268-269.
    • (1991) Lancet , vol.337 , pp. 268-269
    • Bailey, D.G.1    Spence, J.D.2    Munoz, C.3    Arnold, J.M.4
  • 2
    • 0025952282 scopus 로고
    • Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans
    • Soons PA, Vogels BA, Roosemalen MC, et al. Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans. Clin Pharmacol Ther. 1991 ; 50: 394-403.
    • (1991) Clin Pharmacol Ther , vol.50 , pp. 394-403
    • Soons, P.A.1    Vogels, B.A.2    Roosemalen, M.C.3
  • 3
    • 3142523464 scopus 로고    scopus 로고
    • Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin
    • Lilja JJ, Neuvonen M., Neuvonen PJ Effects of regular consumption of grapefruit juice on the pharmacokinetics of simvastatin. Br J Clin Pharmacol. 2004 ; 58: 56-60.
    • (2004) Br J Clin Pharmacol , vol.58 , pp. 56-60
    • Lilja, J.J.1    Neuvonen, M.2    Neuvonen, P.J.3
  • 4
    • 0031954328 scopus 로고    scopus 로고
    • Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid
    • Kantola T., Kivisto KT, Neuvonen PJ Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid. Clin Pharmacol Ther. 1998 ; 63: 397-402.
    • (1998) Clin Pharmacol Ther , vol.63 , pp. 397-402
    • Kantola, T.1    Kivisto, K.T.2    Neuvonen, P.J.3
  • 5
    • 0027363392 scopus 로고
    • Trough concentration of cyclosporine in blood following administration with grapefruit juice
    • Ducharme MP, Provenzane R., Dehoorne-Smith M., Edwards DJ Trough concentration of cyclosporine in blood following administration with grapefruit juice. Br J Clin Pharmacol. 1993 ; 36: 457-459.
    • (1993) Br J Clin Pharmacol , vol.36 , pp. 457-459
    • Ducharme, M.P.1    Provenzane, R.2    Dehoorne-Smith, M.3    Edwards, D.J.4
  • 6
    • 0029055363 scopus 로고
    • Disposition of intravenous and oral cyclosporine after administration with grapefruit juice
    • Ducharme MP, Warbasse LH, Edwards DJ Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharmacol Ther. 1995 ; 57: 485-491.
    • (1995) Clin Pharmacol Ther , vol.57 , pp. 485-491
    • Ducharme, M.P.1    Warbasse, L.H.2    Edwards, D.J.3
  • 7
    • 0030982634 scopus 로고    scopus 로고
    • Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression
    • Lown KS, Bailey DG, Fontana RJ, et al. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest. 1997 ; 99: 2545-2553.
    • (1997) J Clin Invest , vol.99 , pp. 2545-2553
    • Lown, K.S.1    Bailey, D.G.2    Fontana, R.J.3
  • 8
    • 0342868292 scopus 로고    scopus 로고
    • Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity
    • Guo LQ, Fukuda K., Ohta T., Yamazoe Y. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity. Drug Metab Dispos. 2000 ; 28: 766-771.
    • (2000) Drug Metab Dispos , vol.28 , pp. 766-771
    • Guo, L.Q.1    Fukuda, K.2    Ohta, T.3    Yamazoe, Y.4
  • 9
    • 0033976593 scopus 로고    scopus 로고
    • Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model
    • Takanage H., Ohnishi A., Matsuo H., et al. Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model. Br J Clin Pharmacol. 2000 ; 49: 49-58.
    • (2000) Br J Clin Pharmacol , vol.49 , pp. 49-58
    • Takanage, H.1    Ohnishi, A.2    Matsuo, H.3
  • 10
    • 0030696487 scopus 로고    scopus 로고
    • Mechanisms of enhanced oral bioavailability of CYP3A4 substrates by grapefruit constitutes: Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
    • Schmiedlin-Ren P., Edwards DJ, Fitzsimmons ME, et al. Mechanisms of enhanced oral bioavailability of CYP3A4 substrates by grapefruit constitutes: decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos. 1997 ; 25: 1228-1233.
    • (1997) Drug Metab Dispos , vol.25 , pp. 1228-1233
    • Schmiedlin-Ren, P.1    Edwards, D.J.2    Fitzsimmons, M.E.3
  • 11
    • 0035108539 scopus 로고    scopus 로고
    • Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol
    • Spahn-Langguth H., Langguth P. Grapefruit juice enhances intestinal absorption of the P-glycoprotein substrate talinolol. Eur J Pharm Sci. 2001 ; 12: 361-367.
    • (2001) Eur J Pharm Sci , vol.12 , pp. 361-367
    • Spahn-Langguth, H.1    Langguth, P.2
  • 12
    • 0036288273 scopus 로고    scopus 로고
    • Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates
    • Tian R., Koyabu N., Takanaga H., Matsuo H., Ohtani H., Sawada Y. Effects of grapefruit juice and orange juice on the intestinal efflux of P-glycoprotein substrates. Pharm Res. 2002 ; 19: 801-809.
    • (2002) Pharm Res , vol.19 , pp. 801-809
    • Tian, R.1    Koyabu, N.2    Takanaga, H.3    Matsuo, H.4    Ohtani, H.5    Sawada, Y.6
  • 13
    • 0036159433 scopus 로고    scopus 로고
    • Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine
    • Dresser GK, Bailey DG, Leake BF, et al. Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine. Clin Pharmacol Ther. 2002 ; 71: 11-20.
    • (2002) Clin Pharmacol Ther , vol.71 , pp. 11-20
    • Dresser, G.K.1    Bailey, D.G.2    Leake, B.F.3
  • 14
    • 15344340313 scopus 로고    scopus 로고
    • Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B
    • Satoh H., Yamashita F., Tsujimoto M., et al. Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B. Drug Metab Dispos. 2005 ; 33: 518-523.
    • (2005) Drug Metab Dispos , vol.33 , pp. 518-523
    • Satoh, H.1    Yamashita, F.2    Tsujimoto, M.3
  • 15
    • 33947420519 scopus 로고    scopus 로고
    • Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice
    • Bailey DG, Dresser GK, Leake BF, Kim RB Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice. Clin Pharmacol Ther. 2007 ; 81: 495-502.
    • (2007) Clin Pharmacol Ther , vol.81 , pp. 495-502
    • Bailey, D.G.1    Dresser, G.K.2    Leake, B.F.3    Kim, R.B.4
  • 18
    • 21144451094 scopus 로고    scopus 로고
    • Vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
    • OHare T., Walters DK, Stoffregen EP, et al. In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res. 205 ; 65: 4500-4505.
    • Cancer Res , vol.205 , Issue.65 , pp. 4500-4505
    • Ohare, T.1    Walters, D.K.2    Stoffregen, E.P.3
  • 19
    • 13844251975 scopus 로고    scopus 로고
    • Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
    • Weisberg E., Manley PW, Breitenstein W., et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell. 2005 ; 7: 129-141.
    • (2005) Cancer Cell , vol.7 , pp. 129-141
    • Weisberg, E.1    Manley, P.W.2    Breitenstein, W.3
  • 21
    • 57749174353 scopus 로고    scopus 로고
    • Clinical pharmacokinetics (PK) of AMN107, a novel inhibitor of Bcr-Abl, in healthy subjects and patients with imatinib resistant or intolerant chronic myelogenous leukemia (CML) or relapsed/refractory Ph+ acute lymphocytic leukemia (Ph+ALL) [abstract]
    • Tanaka C., Smith T., Kantarjian H., et al. Clinical pharmacokinetics (PK) of AMN107, a novel inhibitor of Bcr-Abl, in healthy subjects and patients with imatinib resistant or intolerant chronic myelogenous leukemia (CML) or relapsed/refractory Ph+ acute lymphocytic leukemia (Ph+ALL) [abstract]. J Clin Oncol. 2006 ; 24: 18S.
    • (2006) J Clin Oncol , vol.24
    • Tanaka, C.1    Smith, T.2    Kantarjian, H.3
  • 22
    • 0037427972 scopus 로고    scopus 로고
    • The superfamily of organic anion transporting polypeptides
    • Hagenbuch B., Meier PJ The superfamily of organic anion transporting polypeptides. Biochem Biophys Acta. 2003 ; 1609: 1-18.
    • (2003) Biochem Biophys Acta , vol.1609 , pp. 1-18
    • Hagenbuch, B.1    Meier, P.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.